Eidos Therapeutics
Latest round
- Series B
Last raised
- Mar 2018
Total raised
- $26M
Investors
- 8
About Eidos Therapeutics
Founded in 2016 and based in California, US, Eidos Therapeutics, Inc. operates as a biotechnology company that focuses on the development of novel oral therapeutics to treat patients with transthyretin (TTR) amyloidosis (ATTR).
Who invested in Eidos Therapeutics
8 investors across 1 round
See all investors in Eidos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 29, 2018
Amount
$26M
Investors
Questions about Eidos Therapeutics
Who invested in Eidos Therapeutics?
Eidos Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eidos Therapeutics raised?
Eidos Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eidos Therapeutics last raise money?
Eidos Therapeutics's most recent round on record is a Series B, in Mar 2018.
What does Eidos Therapeutics do?
Founded in 2016 and based in California, US, Eidos Therapeutics, Inc.
Where is Eidos Therapeutics headquartered?
Eidos Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Eidos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eidos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Eidos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.